Priority Date: 08.06.12 (US 201261657484P)

MUTANT SELECTIVITY AND COMBINATIONS OF A PHOSPHOINOSITIDE 3 KINASE INHIBITOR COMPOUND AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER

  • Application ID: EP13729649
  • Status: GRANT OF PATENT INTENDED

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
1 office
Technology Company

Specialization

This EP application has the IPC combination A61, C12, and G01. We found, that TransMIT GmbH, Kailuweit & Uhlemann, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Avidity IP Ltd, Mewburn Ellis LLP and 75 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 08.06.2012 - Priority Date (US 201261657484P)
  • 12.12.2013 - Publication A1 (WO2013182668)
  • 15.04.2015 - Publication A1 (EP2858666)